YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors

dc.authorid Cihan, Sener/0000-0002-3960-4982
dc.authorid Can, Orcun/0000-0002-9400-105X
dc.authorid Arici, Serdar/0000-0003-2018-6554
dc.authorid Sakin, Abdullah/0000-0003-2538-8569
dc.authorid Geredeli, Caglayan/0000-0002-3982-7465
dc.authorscopusid 55293011200
dc.authorscopusid 57204774164
dc.authorscopusid 57204771705
dc.authorscopusid 24823118000
dc.authorscopusid 55189913500
dc.authorscopusid 19834529300
dc.authorscopusid 19834529300
dc.authorwosid Yaşar, Nurgül/Gpk-1197-2022
dc.authorwosid Cihan, Şener/Aaw-1956-2021
dc.authorwosid Can, Orçun/Agx-9627-2022
dc.authorwosid Geredeli, Caglayan/Aan-4122-2020
dc.authorwosid Arici, Serdar/Aan-4106-2020
dc.contributor.author Sakin, Abdullah
dc.contributor.author Can, Orcun
dc.contributor.author Arici, Serdar
dc.contributor.author Yasar, Nurgul
dc.contributor.author Geredeli, Caglayan
dc.contributor.author Demir, Cumhur
dc.contributor.author Cihan, Sener
dc.date.accessioned 2025-05-10T17:25:45Z
dc.date.available 2025-05-10T17:25:45Z
dc.date.issued 2019
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Sakin, Abdullah] Yuzuncu Yil Univ, Dept Med Oncol, Med Sch, Van, Turkey; [Can, Orcun; Arici, Serdar; Yasar, Nurgul; Geredeli, Caglayan; Demir, Cumhur; Cihan, Sener] Univ Hlth Sci, Okmeydani Training & Res Hosp, Dept Med Oncol, Istanbul, Turkey en_US
dc.description Cihan, Sener/0000-0002-3960-4982; Can, Orcun/0000-0002-9400-105X; Arici, Serdar/0000-0003-2018-6554; Sakin, Abdullah/0000-0003-2538-8569; Geredeli, Caglayan/0000-0002-3982-7465 en_US
dc.description.abstract Background: Possibly originating from interstitial Cajal cells, gastrointestinal stromal tumors (GISTS) have variable biological behaviors. In this study, we aimed to examine the factors affecting the disease-free survival (DFS) in patients with GIST who underwent operation. Material and methods: The study included the patients who were followed up and treated for GIST in our oncology clinic between 2002 and 2017. The Armed Forces Institute of Pathology criteria (Miettinen risk score) were used for risk stratification of patients. Results: Seventy-four patients were included to the study, where female patients constituted 52.7%, and the median age was 56 (range: 24-83) y. Most common primary tumor location was the stomach (51.4%), followed by the small intestine (33.8%), colorectum (10.8%), and retroperitoneum (4.1%). Miettinen risk score showed 12 patients (16.7%) at very low risk, 15 patients (20.8%) at low risk, 18 patients (25%) at intermediate risk, and 27 patients (37.5%) at high risk. DFS was significantly lower in patients with small intestine involvement than in cases with stomach involvement (P = 0.004). DFS was significantly lower in patients at high risk than in patients with no high risk (P = 0.034). Small intestine localization (hazard ratio [HR], 8.98; 95% confidence interval [CI], 1.14-8.18), high-risk score (HR, 5.16; 95% CI, 1.42-12.75), c-kit positivity (HR, 0.24; 95% CI, 0.13-0.69), and adjuvant therapy (HR, 0.37; 95% CI, 0.20-0.92) were found to be the most significant factors affecting DFS. Conclusions: Our study showed negative effects of small intestine localization and high-risk category and positive effects of c-kit positivity and adjuvant therapy on DFS in patients with GIST who underwent operation. When a decision will be made in favor of adjuvant therapy, tumor localization and c-kit mutation should also be considered in addition to risk score. (C) 2019 Elsevier Inc. All rights reserved. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1016/j.jss.2019.03.059
dc.identifier.endpage 177 en_US
dc.identifier.issn 0022-4804
dc.identifier.issn 1095-8673
dc.identifier.pmid 31026795
dc.identifier.scopus 2-s2.0-85064549580
dc.identifier.scopusquality Q1
dc.identifier.startpage 170 en_US
dc.identifier.uri https://doi.org/10.1016/j.jss.2019.03.059
dc.identifier.uri https://hdl.handle.net/20.500.14720/11468
dc.identifier.volume 241 en_US
dc.identifier.wos WOS:000471137000025
dc.identifier.wosquality Q2
dc.language.iso en en_US
dc.publisher Academic Press inc Elsevier Science en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Gastrointestinal Stromal Tumor en_US
dc.subject Disease-Free Survival en_US
dc.subject Imatinib en_US
dc.subject Overall Survival en_US
dc.title Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors en_US
dc.type Article en_US

Files